Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesDividends payablesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Vycor Medical (VYCO) Liabilities and Shareholders Equity (2016 - 2025)

Vycor Medical has reported Liabilities and Shareholders Equity over the past 16 years, most recently at $830420.0 for Q4 2025.

  • Quarterly Liabilities and Shareholders Equity fell 16.8% to $830420.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.6 million through Dec 2025, down 11.07% year-over-year, with the annual reading at $830420.0 for FY2025, 16.8% down from the prior year.
  • Liabilities and Shareholders Equity was $830420.0 for Q4 2025 at Vycor Medical, down from $941195.0 in the prior quarter.
  • Over five years, Liabilities and Shareholders Equity peaked at $1.1 million in Q3 2024 and troughed at $830420.0 in Q4 2025.
  • The 5-year median for Liabilities and Shareholders Equity is $945505.5 (2022), against an average of $953877.4.
  • Year-over-year, Liabilities and Shareholders Equity rose 16.0% in 2024 and then fell 16.8% in 2025.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $935364.0 in 2021, then fell by 8.04% to $860178.0 in 2022, then rose by 15.36% to $992298.0 in 2023, then rose by 0.59% to $998117.0 in 2024, then decreased by 16.8% to $830420.0 in 2025.
  • Per Business Quant, the three most recent readings for VYCO's Liabilities and Shareholders Equity are $830420.0 (Q4 2025), $941195.0 (Q3 2025), and $878946.0 (Q2 2025).